Check out the latest news from Cinclus Pharma
On June 12, Christer Ahlberg, CEO of Cinclus Pharma, will present the company and the development of the drug candidate linaprazan glurate at Aktiespararnas event Småbolagsdagarna.
Read more
Here you can watch the full presentation of CInclus Pharma and the development of linaprazan glurate, held by CEO Christer Ahlberg at ABGSC Investor Days.
Read more
Cinclus Pharma participates at Redeye Growth Day May 30th. Christer Ahlberg, CEO of Cinclus Pharma, will present the company and the development of linaprazan glurate.
Read more